Page last updated: 2024-08-22

stavudine and Diabetes Mellitus, Type 2

stavudine has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Apalata, T; Bam, NE; Chitha, W; Mabunda, SA; Nomatshila, SC; Ntsaba, J	1
Dehayem, MY; Echouffo-Tcheugui, JB; Ekali, LG; Fezeu, L; Hayes, L; Johnstone, LK; Kouanfack, C; Nouthe, B; Sobngwi, E; Unwin, NC	1
Brambilla, AM; Calori, G; Castagna, A; Lazzarin, A; Luzi, L; Meneghini, E; Novati, R; Vacchini, D	1

Trials

1 trial(s) available for stavudine and Diabetes Mellitus, Type 2

Article	Year
The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: A case-control study. PloS one, 2020, Volume: 15, Issue:12 Topics: Adult; Diabetes Mellitus, Type 2; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Rural Population; South Africa; Stavudine; Time Factors; Zidovudine	2020

Other Studies

2 other study(ies) available for stavudine and Diabetes Mellitus, Type 2

Article	Year
Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment. Diabetes & metabolism, 2013, Volume: 39, Issue:1 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Blood Pressure; Body Fat Distribution; Cameroon; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Health Services Accessibility; HIV Infections; Humans; Insulin Resistance; Lipids; Male; Stavudine; Time Factors	2013
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals. AIDS (London, England), 2003, Sep-05, Volume: 17, Issue:13 Topics: Adolescent; Adult; Age Factors; Aged; Anti-HIV Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Indinavir; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine	2003

Article

Year

Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.

Diabetes & metabolism, 2013, Volume: 39, Issue:1

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Glucose; Blood Pressure; Body Fat Distribution; Cameroon; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Health Services Accessibility; HIV Infections; Humans; Insulin Resistance; Lipids; Male; Stavudine; Time Factors

2013

Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.

AIDS (London, England), 2003, Sep-05, Volume: 17, Issue:13

Topics: Adolescent; Adult; Age Factors; Aged; Anti-HIV Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Indinavir; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine

2003